STOCKHOLDERS' EQUITY (Tables)
|
6 Months Ended |
Jul. 31, 2026 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Stock-based Compensation Expense |
The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended July 31, | | Six Months Ended July 31, | | 2026 | | 2025 | | 2026 | | 2025 | Cost of revenue | $ | 6,199 | | | $ | 5,399 | | | $ | 12,094 | | | $ | 10,064 | | Research and development | 28,401 | | | 24,289 | | | 57,349 | | | 45,230 | | Sales and marketing | 21,472 | | | 21,338 | | | 41,757 | | | 44,253 | | General and administrative | 25,221 | | | 22,858 | | | 44,982 | | | 43,028 | | Restructuring | 10,821 | | | — | | | 10,821 | | | (36) | | Total | $ | 92,114 | | | $ | 73,884 | | | $ | 167,003 | | | $ | 142,539 | |
|
| Schedule of Restricted Stock Units |
A summary of our RSU activity is as follows:
| | | | | | | | | | | | | Number of RSUs | | Weighted-Average Grant Date Fair Value | Outstanding as of January 31, 2026 | 31,653,685 | | | $ | 18.99 | | Granted | 23,559,499 | | | 13.60 | | | Released | (6,243,585) | | | 19.44 | | | Forfeited | (5,751,782) | | | 17.50 | | Outstanding as of July 31, 2026 | 43,217,817 | | | $ | 16.19 | |
|
| Schedule of Performance Stock Units |
A summary of our PSU activity is as follows: | | | | | | | | | | | | | Number of PSUs | | Weighted-Average Grant Date Fair Value | Outstanding as of January 31, 2026 | 1,246,801 | | | $ | 17.06 | | | Granted | 1,535,924 | | | 15.74 | | | Released | (477,776) | | | 17.39 | | Forfeited | (130,715) | | | 17.06 | | Outstanding as of July 31, 2026 | 2,174,234 | | | $ | 16.06 | |
|
| Schedule of Stock Options |
A summary of our stock option activity is as follows:
| | | | | | | | | | | | | | | | | Number of Options | | Weighted-Average Exercise Price | | | | | Outstanding as of January 31, 2026 | 9,443,196 | | | $ | 6.92 | | | | | | | | | | | | | | | Exercised | (957,402) | | | 3.29 | | | | | | | Forfeited | (17,252) | | | 1.64 | | | | | | Outstanding as of July 31, 2026 | 8,468,542 | | | $ | 7.34 | | | | | | Vested and expected to vest as of July 31, 2026 | 8,468,542 | | | $ | 7.34 | | | | | | Vested and exercisable as of July 31, 2026 | 6,895,757 | | | $ | 7.14 | | | | | |
|
| Schedule of Restricted Common Stock |
Restricted common stock is included in issued and outstanding shares as they are legally issued and outstanding but are not deemed outstanding for accounting purposes until the shares vest. A summary of our restricted common stock activity is as follows:
| | | | | | | | | | | | | Number of Shares | | Weighted-Average Grant Date Fair Value | Outstanding as of January 31, 2026 | 3,484,135 | | | $ | 20.60 | | | | | | Vested | (1,120,114) | | | 23.82 | | Unvested balance as of July 31, 2026 | 2,364,021 | | | $ | 19.07 | |
|